Home > Insider Trading > Filing (0001628280-25-029800)

Filing Details

Accession Number:: 0001628280-25-029800
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-06-05 20:05:17
Reporting Period:: 2025-06-03

Filing Date:: 2025-06-05
Accepted Time:: 2025-06-05 20:05:17
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1588978	Procept Biorobotics Corp	PRCT	Surgical & Medical Instruments & Apparatus (3841)	260199180

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1881616	Rohit Antal Desai	C/O Procept Biorobotics Corporation 150 Baytech Drive San Jose CA 95134		Yes	No	No	No

Transaction Summary

Sold:	75,000 shares	Avg. Price: $62.16	Total Value: $4,661,860.99
Number of Shares After Transactions:	89,363 shares

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2025-06-03	900	$58.04	163,463	No	4	S	Indirect	By The 2:22 DNA Trust
Common Stock	Disposition	2025-06-03	1,100	$59.14	162,363	No	4	S	Indirect	By The 2:22 DNA Trust
Common Stock	Disposition	2025-06-03	9,880	$60.23	152,483	No	4	S	Indirect	By The 2:22 DNA Trust
Common Stock	Disposition	2025-06-03	11,602	$61.22	140,881	No	4	S	Indirect	By The 2:22 DNA Trust
Common Stock	Disposition	2025-06-03	1,518	$61.83	139,363	No	4	S	Indirect	By The 2:22 DNA Trust
Common Stock	Disposition	2025-06-04	16,400	$60.82	122,963	No	4	S	Indirect	By The 2:22 DNA Trust
Common Stock	Disposition	2025-06-04	8,600	$61.40	114,363	No	4	S	Indirect	By The 2:22 DNA Trust
Common Stock	Disposition	2025-06-05	700	$61.85	113,663	No	4	S	Indirect	By The 2:22 DNA Trust
Common Stock	Disposition	2025-06-05	1,706	$63.07	111,957	No	4	S	Indirect	By The 2:22 DNA Trust
Common Stock	Disposition	2025-06-05	5,946	$64.19	106,011	No	4	S	Indirect	By The 2:22 DNA Trust
Common Stock	Disposition	2025-06-05	12,548	$65.09	93,463	No	4	S	Indirect	By The 2:22 DNA Trust
Common Stock	Disposition	2025-06-05	4,000	$65.94	89,463	No	4	S	Indirect	By The 2:22 DNA Trust
Common Stock	Disposition	2025-06-05	100	$66.73	89,363	No	4	S	Indirect	By The 2:22 DNA Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By The 2:22 DNA Trust
No	4	S	Indirect	By The 2:22 DNA Trust
No	4	S	Indirect	By The 2:22 DNA Trust
No	4	S	Indirect	By The 2:22 DNA Trust
No	4	S	Indirect	By The 2:22 DNA Trust
No	4	S	Indirect	By The 2:22 DNA Trust
No	4	S	Indirect	By The 2:22 DNA Trust
No	4	S	Indirect	By The 2:22 DNA Trust
No	4	S	Indirect	By The 2:22 DNA Trust
No	4	S	Indirect	By The 2:22 DNA Trust
No	4	S	Indirect	By The 2:22 DNA Trust
No	4	S	Indirect	By The 2:22 DNA Trust
No	4	S	Indirect	By The 2:22 DNA Trust

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 5, 2024.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.65 to $58.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.73 to $59.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.74 to $60.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.74 to $61.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.74 to $61.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.13 to $61.125, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.13 to $61.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.60 to $62.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.65 to $63.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.67 to $64.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.68 to $65.67, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.69 to $66.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.